# Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

> **NCT00335686** · PHASE4 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 67 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir-rtv (Kaletra): 3 capsules (600 mg)/12 h
- **DRUG:** Nevirapine (Viramune): 1 comp (200mg)/12h

## Key facts

- **NCT ID:** NCT00335686
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2008-02-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335686, "Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00335686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*